Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Equities research analysts at StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the stock. Oragenics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback